A detailed history of Clark & Stuart, Inc transactions in Amgen Inc stock. As of the latest transaction made, Clark & Stuart, Inc holds 635 shares of AMGN stock, worth $216,985. This represents 0.14% of its overall portfolio holdings.

Number of Shares
635
Holding current value
$216,985
% of portfolio
0.14%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 07, 2026

BUY
$290.13 - $341.71 $184,232 - $216,985
635 New
635 $208 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Clark & Stuart, Inc Portfolio

Follow Clark & Stuart, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark & Stuart, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Clark & Stuart, Inc with notifications on news.